Cannabis Rescheduling Gains Momentum as Trump and DEA Signal Priority
With Trump open to cannabis rescheduling and the DEA making it a priority, industry leaders see a historic shift ahead. Schedule III could ease taxes, boost research, and spur growth—but experts warn it’s only the first step toward real federal reform.
